The use of paracetamol (acetaminophen) among a community sample of people with chronic non-cancer pain prescribed opioids

Grants

Funding Acknowledgements

We thank Gabrielle Campbell, Jessica Belcher, Sarah Freckleton, Anika Martin, Ranira Moodley, Kimberley Smith and Rachel Urquhart-Secord, NDARC, for their contribution to data collection. We also thank Cerissa Papanastasiou, Burnet Institute, for her contribution to some of the POINT data collection in Melbourne. We thank the Pharmacy Guild of Australia, the NSW Pharmacy Guild and Pain Australia, for their support of this study and assistance with dissemination. We also thank the POINT advisory committee for their advice on the design and conduct of the study.This study received funding from the Australian National Health and Medical Research Council (NHMRC, #1022522). L.D., B.L., S.N., N.G. and W.H. are supported by NHMRC research fellowships (#1041472, #1073858, #1013803, #569738, #1091878 and #1045318). The National Drug and Alcohol Research Centre at the University of NSW was supported by funding from the Australian Government under the Substance Misuse Prevention and Service Improvements Grant Fund. Cerissa Papanastasiou was supported by funding provided to Paul Dietze and L.D. by the Victorian Drug Law Enforcement Fund.